PHARMACY EDUCATION AND PRACTISE
CHALLENGES TO MEET FUTURE PROFESSIONAL NEEDS
JAIPUR NATIONAL UNIVERSITY
Pharmaceutical Industry -An Overview
Pharmaceutical Industry the propeller for other Industries
In around 1640 BC Dhanvantari wrote a treatise on Medicine,
Pharmaceutics, & surgery.
During around 500 BC Buddhist Monks spread to
the rest of the world
The History of Pharmaceutical Indus can be traced to 1600 BC
Modern day Medication
Modern day Medication more than 350 years old
In 1901 Acharya P.C. Ray started first Indian Pharmaceutical company
1970s saw the emergence of Indian Pharmaceutical Industry. Research &
Development in later part of 19th Century and 20th Century.
This led to the expansion of Bulk Drug Industry
Present global market size $ 825 Billion growing @ 4 to 6 %
India 3rd largest producer of Pharmaceuticals having 10%
of the global share.
Cardiovascular segment dominates the sales with 50%
share and Anti Diabetic segment has a share of 22 %
Pharmaceutical biotechnology, pharmacogenomics, combinatorial chemistry, screening
technologies, and bioinformatics are major advances that give a new direction to
Pharmaceutical education has to set new priorities to keep pace with the challenges
related to genomic technologies.
Educators and pharmacy school members have the responsibility of deciding how, to
what extent, by which methods, and/or in which way these changes and new directions
in the education programs should be developed.
Need to better integrate internationally educated pharmacists within the domestic
workforce and professional development and maintenance of competency of
Reasons of strong education system
• Changes in medical environments such as collapse of doctors' paternalism
• To meet these social needs the education of students in pharmaceutical colleges should
be reconstructed extensively from a traditional research-oriented system to a patientcentered system, applied pharmacotherapy is to be strengthened and enforced.
• The pharmacy academy is well positioned to prepare graduates to become more
proactive in creating a safer health care environment for patients.
A drastic reform of pharmacist education should be brought in effect.
Indian Pharmaceutical Evolution
of organized Indian
•New IP law
•Rapid expansion of
•Indian Patent Act –
Innovation and Research
•Drug prices capped
•Local companies begin
to make an impact
Pharmacists Roles in Patient Care
Pharmacists as drug therapy managers
Assessing, counseling and monitoring drug therapy
Dealing with medication misadventures: $177 billion drug morbidity/mortality
Overseeing medication management systems
Delivering pharmaceutical care: could save over $105 billion annually if universally
Continued creation of opportunities for new service development in the community:
Residency programs in community practice
Participation in demonstration projects, e.g. Patient Self-Management: Diabetes
Partnerships with education and practice organizations
• Indian - Bulk Drugs & Formulation M/S Market
Current and Projected Need for Pharmacists
2001: 200,000 active pharmacists
2020 projection: 260,000 active pharmacists
2020 Forecast Need
Based on new graduates, adjusted for those
leaving; assumes 20% enrollment growth
existing schools and 3 new ones in addition to
those slated to open
Outpatient prescriptions: 7,500,000,000
Hospital drug orders: 3,000,000,000 (+2.5%/yr)
Community Pharmacy, 2020: 7,500,000,000
172,000 community pharmacists
One prescription every 2 ¾ minutes
Hospital Pharmacy, 2020:
65,000 hospital pharmacists
One order every 2 minutes
Challenges for Educators
Faculty needs: new models & partnerships with
Training sites: new models, residencies
Curriculum to address distributive/patient care
Technology application to both: e.g. distance
Sharing resources across institutions
Financing for expansion in era of state budget
A strong background in basic science is
sufficient for an entry level since materials
science, processing and product development
Implications for Educators: How
to Expand the Profession?
• Good news: today’s graduates are being educated at level
consistent with profession’s long-term patient care vision
• Many new opportunities for pharmacists, especially with
doctoral level training
Enrollments by Expected Graduation Year
*Data for expected graduation for years 2003-06 from Profile of Pharm acy Students Fall 2002. For years 2000-02 from
Profile of Pharm acy Students Fall 1999.
Challenges for Industry
Lack of proper infrastructure
Lack of qualified professionals
Expensive research equipments
Lack of academic collaboration
Underdeveloped molecular discovery program
Divide between the industry and study curriculum
Indian - Bulk Drugs Formulation Large
Sales Turnover and Reported Net Profit on 2010 (in Rs. Crore)
There is a current shortage of entry-level scientists
with an appropriate background in product
development and pharmaceutical technology.
The government of India has undertaken several including policy initiatives and tax
breaks for the growth of the pharmaceutical business in India. Some of the
measures adopted are:
1. Pharmaceutical units are eligible for weighted tax reduction at 150% for the
research and development expenditure obtained.
2. Two new schemes namely, New Millennium Indian Technology Leadership
Initiative and the Drugs and Pharmaceuticals Research Program have been
launched by the Government.
3. The Government is contemplating the creation of SRV or special purpose vehicles
with an insurance cover to be used for funding new drug research
4. The Department of Pharmaceuticals is mulling the creation of drug research
facilities which can be used by private companies for research work on rent
Indian - Bulk Drugs & Formulation Large
• Market Share at Present
TOP TEN INDIAN COMAPNIES
1. Ranbaxy Labs
3. Dr Reddy’s Labs
4. Aurobindo Pharma
5. Piramal Health
6.Sun Pharma Inds.
8. Cardila Heath
9. Ipca Labs
10. Torrent Pharma
Indian Pharma Industry – Future
The Indian pharma industry is still trying to come to terms with the
new patent regime.
Over the next 5 years, will continue to grow by at least twice the
rate of global growth.
Retail segment will be the fastest growing segment.
There will be a significant increase in the clinical trials and
A significant window of opportunity will be available expiring
To meet future professional needs- also
requires Foreign Investment
– Indian drug industry has in the last five years seen half a dozen big takeovers by
– $3.6 billion acquisition of promoters’ stake in Ranbaxy Laboratories by Japan’s
Daiichi Sankyo Co. Ltd.
US drug maker Mylan Inc. paid $734 million to acquire Hyderabad-based Matrix
– German health care group Fresenius SE spent $219 million to take over Dabur
– US drug and nutrition firm Abbott Laboratories paid $3.72 billion to acquire
Piramal Healthcare Ltd’s domestic drug formulation business and spent $726
million to buy out Ahmedabad-based consumer health company Paras
French drug multinational Sanofi-Aventis SA acquired a majority stake in Indian
vaccines company Shanta Biotech for €550 million
Essential drugs at affordable prices are
available and also continue providing
employment for millions.
Major global player in the field of
pharmaceuticals exports and as a
provider of quality medicines at low
Major player in the generic drugs
market in USA and Europe.
Attain new heights in herbal drugs
research in shaping Indian Systems of
Medicine into a popular system of
medicine of the future for holistic
health care and ensuring health care
for all - especially for the welfare of